Evidence map›Paper›PMID 42275394›Full record

ReviewPLOS digital health2026

Clinical artificial intelligence applications of vision-language foundation models.

Arun James Thirunavukarasu, Siyou Li, Pengyao Qin, Dong Nie, Rohan Sanghera, Ernest Lim, Juntao Yu, Le Zhang

Abstract readReview
In one paragraph

Review in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arun James ThirunavukarasuDepartment of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-8968-4768
Siyou LiSchool of Electronic Engineering and Computer Science, Queen Mary University of London, London, United Kingdom.ORCID https://orcid.org/0009-0007-6840-5791
Pengyao QinSchool of Engineering, College of Engineering and Physical Sciences, University of Birmingham, Birmingham, United Kingdom.
Dong NieMeta AI, Meta Platforms Inc., Menlo Park, California, United States of America.
Rohan SangheraDepartment of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
Ernest LimInstitute for Safe Autonomy, University of York, York, United Kingdom.ORCID https://orcid.org/0000-0002-6972-0511
Juntao YuSchool of Electronic Engineering and Computer Science, Queen Mary University of London, London, United Kingdom.ORCID https://orcid.org/0000-0001-7971-9154
Le ZhangSchool of Engineering, College of Engineering and Physical Sciences, University of Birmingham, Birmingham, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vision-language models (VLMs) represent a transformative advance in generative artificial intelligence (AI), using multimodal data processing to enhance clinical decision-making and workflow efficiency. Built on transformer architectures, VLMs excel in tasks like image interpretation, report generation, and visual question-answering, with emerging applications in radiology, pathology, and broader clinical practice. Their potential extends to automating documentation, improving medical education, and assisting with clinical decision-making in real-time. However, successful integration requires rigorous validation to address challenges such as bias, interpretability, and safety concerns. Prospective clinical trials, health economic evaluations, and stakeholder engagement are essential to ensure equitable and effective deployment. Regulatory frameworks must evolve to accommodate VLM functionality while maintaining accountability and protecting patient safety. By balancing innovation with robust oversight, VLMs hold promise in reducing clinician workload, expanding access to expert care, and advancing precision medicine-ushering in a new era of AI-augmented healthcare.

Identifiers

PMID42275394
PMCPMC13257963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.